White Blood Cell and Neutrophil Counts and Response to Intravenous Immunoglobulin in Kawasaki Disease. (October 2019)

• Record Type: Journal Article
• Authors: Muto, Taichiro; Masuda, Yu; Numoto, Shingo; Kodama, Shunsuke; Yamakawa, Kiyoshi; Takasu, Michihiko; Hayakawa, Tomohito; Miyata, Kenji; Miyamoto, Ryosuke; Akaihata, Mitsuko; Iwayama, Hideyuki; Kitagawa, Yoshiro; Kurahashi, Hirokazu; Shimomura, Yasuto; Hori, Toshinori; Okuda, Masumi; Agata, Hiroatsu; Okumura, Akihisa
• Is Part Of: Global pediatric health. Volume 6(2019)
• Publication Date: 2019-10
• Subjects: Kawasaki disease -- intravenous immunoglobulin -- white blood cell counts -- neutrophil counts -- nonresponder; Pediatrics -- Periodicals; Children -- Health and hygiene -- Periodicals; 618.92
• DOI: 10.1177/2333794X19884826
• Languages: English
• ISSNs: 2333-794X

Abstract

We explored parameters to predicting the efficacy of intravenous immunoglobulin (IVIG) therapy for patients with Kawasaki disease (KD). We retrospectively analyzed the laboratory data of 77 children with KD treated with IVIG. Data obtained before and within 24 hours after IVIG therapy were compared between responders and nonresponders. The white blood cell (WBC) and neutrophil counts were significantly lower in responders than nonresponders within 24 hours after IVIG. The areas under the receiver operating characteristics curves of the WBC and neutrophil counts were 0.846 and 0.754, respectively. The WBC and neutrophil counts differed significantly between responders and nonresponders (the latter developed recurrent pyrexia after transient fever resolution). In conclusion, WBC and neutrophil counts within 24 hours after IVIG usefully predict the efficacy of IVIG therapy for those with KD, and identify nonresponders to such therapy.